Advertisement
Home Tags Psoriasis

Tag: Psoriasis

Ixekizumab

Ixekizumab Shows Promise in Psoriasis Treatment

In phase 3 trials, appeared to outperform standard medication, placebo
Compared with controls

Lower Sleep Quality for Patients With Psoriasis Vulgaris

No significant differences in general psychiatric symptoms, coping strategies for patients, controls
Statin use does not lower the risk of psoriasis

Statins Don’t Reduce Psoriasis Risk

Findings among patients with high, long-term adherence to statins
Methotrexate and cyclosporine have the lowest monthly cost for treating psoriasis

Methotrexate, Cyclosporine Least Costly Meds for Psoriasis

Infliximab, ustekinumab 90 mg most costly therapies based on number needed to treat to achieve PASI 75
Helicobacter pylori (H. pylori) infection may affect the severity of psoriasis

H. Pylori May Impact Severity of Psoriasis

No higher prevalence of H. pylori infection in patients with mild, moderate psoriasis
For patients with psoriasis

AAD: Herpes Zoster Incidence Up With Combo Tx for Psoriasis

Physicians may need to consider offering a herpes zoster preventive vaccine to patients
Patients with psoriasis are less likely to engage in physical activity

Patients With Psoriasis Less Likely to Be Physically Active

Less likely to engage in moderate to vigorous physical activity, especially those with severe disease
For patients with recalcitrant psoriasis associated with episodes of tonsillitis

Tonsillectomy May Benefit Tonsillitis-Associated Psoriasis

Review shows improvement in psoriasis for some patients; improvement not always sustained
The U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.

FDA Approves New Drug to Treat Plaque Psoriasis

Cosentyx hinders protein that spurs skin inflammation